P38α inhibitor 3
P38α inhibitor 3 (Comp G7) is a p38α inhibitor that blocks the effectiveness of myoblast differentiation[1].
Product Specifications
CAS Number
[260428-69-1]
UNSPSC
12352005
Target
P38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/p38α-inhibitor-3.html
Purity
99.82
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N1CCC(CC1)CC2=CC=CC=C2)C3=CC=C(C=C3)F
Molecular Formula
C19H20FNO
Molecular Weight
297.37
References & Citations
[1]Yael Friedmann, et al. JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeast. Mol Pharmacol. 2006 Oct;70 (4) :1395-405.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0536804 1.0 µg DNA
CXorf18 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
GTR15330678 1 Vial
Lentiviral human ZHX1-C8orf76 shRNA (UAS) - Lentiviral human ZHX1-C8orf76 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
MBS6012580-01 0.2 mL
NFKB, p105, CT (S933) (NFKB1, Nuclear factor NF-kappa-B p105 subunit, DNA-binding factor KBF1, EBP-1, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, Nuclear factor NF-kappa-B p50 subunit)
Sign In for Pricing
View Details